PNC Financial Services Group
JANX icon

PNC Financial Services Group’s Janux Therapeutics JANX Stock Holding History

PNC Financial Services Group’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Buy
776
+273
+54% +$3.96K ﹤0.01% 4014
2026
Q1 		$6.99K Buy
503
+498
+9,960% +$6.83K ﹤0.01% 4118
2025
Q4 		$69 Sell
5
-50
-91% -$1.18K ﹤0.01% 5084
2025
Q3 		$1.34K Sell
55
-44
-44% -$1.07K ﹤0.01% 4609
2025
Q2 		$2.29K Buy
+99
New +$2.61K ﹤0.01% 4375

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

PNC Financial Services Group's JANX Position: Q2 2026 in Review

PNC Financial Services Group increased its Janux Therapeutics (JANX) stake by 54% in Q2 2026, buying an estimated $3.96K and bringing the position to 776 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4014.

PNC Financial Services Group first reported a position in JANX in Q2 2025 and has held it in 5 quarters since. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • PNC Financial Services Group held 776 shares of Janux Therapeutics worth $11.9K as of Q2 2026.
  • PNC Financial Services Group bought 273 Janux Therapeutics shares in Q2 2026, an estimated $3.96K.
  • Janux Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4014 holding.
  • PNC Financial Services Group first reported a position in Janux Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.